UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Unicycive Therapeutics, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Unicycive Therapeutics, Inc. for investors who acquired shares between March 29, 2024, and June 27, 2025. The lawsuit alleges that Unicycive misrepresented its compliance with FDA manufacturing requirements, leading to significant stock price drops after negative FDA findings. Investors have until October 14, 2025, to apply as lead plaintiffs. For more information, affected investors are encouraged to contact the law firm directly.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments